Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)

Por Ku, Bo Mi, Heo, Mi Hwa, Kim, Joo-Hang, Cho, Byoung Chul, Cho, Eun Kyung, Min, Young Joo, Lee, Ki Hyeong, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Kim, Tae Jung, Lee, Ho Yun, Kim, Hojoong, Lee, Kyung-Jong, Ahn, Myung-Ju
Publicado no J Pathol Transl Med (2018)

A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)

Por Okajima, Masaaki, Miura, Satoru, Watanabe, Satoshi, Tanaka, Hiroshi, Ito, Kazuhiko, Ishida, Takashi, Makino, Masato, Iwashima, Akira, Matsumoto, Naoya, Sato, Kazuhiro, Ichikawa, Kosuke, Abe, Tetsuya, Yoshizawa, Hirohisa, Kikuchi, Toshiaki
Publicado no Transl Lung Cancer Res (2021)

Foxp3 expression in human cancer cells

Por Karanikas, Vaios, Speletas, Matthaios, Zamanakou, Maria, Kalala, Fani, Loules, Gedeon, Kerenidi, Theodora, Barda, Angeliki K, Gourgoulianis, Konstantinos I, Germenis, Anastasios E
Publicado em 2008

Validation of multivariable lung cancer risk prediction models for the personalized assignment...

Por González Maldonado, Sandra, Hynes, Lucas Cory, Motsch, Erna, Heussel, Claus-Peter, Kauczor, Hans-Ulrich, Robbins, Hilary A., Delorme, Stefan, Kaaks, Rudolf
Publicado no Transl Lung Cancer Res (2021)

Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer

Por Zhang, Zhonghan, Zhang, Yang, Luo, Fan, Ma, Yuxiang, Fang, Wenfeng, Zhan, Jing, Li, Su, Yang, Yunpeng, Zhao, Yuanyuan, Hong, Shaodong, Zhou, Ting, Zhang, Yaxiong, Zhao, Shen, Huang, Yan, Zhao, Hongyun, Zhang, Li
Publicado no Clin Transl Med (2020)

Shashen maidong decoction: the effect of TNF-α and IL-6 on lung cancer cachexia based on cancer toxicity theory

Por He, Meiyan, Luo, Ying, Chen, Lujie, Zeng, Manping, Liao, Qin, Zhang, Wencai, Xie, Hui
Publicado no Am J Transl Res (2021)

Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database

Por Anggondowati, Trisari, Ganti, Apar Kishor, Islam, K. M. Monirul
Publicado no Transl Lung Cancer Res (2020)

Empiric Radiotherapy for Lung Cancer Collaborative Group multi-institutional evidence-based...

Por Berman, Abigail T., Jabbour, Salma K., Vachani, Anil, Robinson, Cliff, Choi, J. Isabelle, Mohindra, Pranshu, Rengan, Ramesh, Bradley, Jeffrey, Simone, Charles B.
Publicado no Transl Lung Cancer Res (2019)

Is chest radiation now a classical practice for extensive small cell lung cancer?

Por Van Houtte, Paul, Moretti, Luigi, Roelandts, Martine
Publicado no Transl Lung Cancer Res (2015)

Functional promoter rs189037 variant of ATM is associated with decrease in lung diffusing capacity after irradiation for non–small-cell lung cancer

Por Lopez Guerra, Jose Luis, Song, Yi-Peng, Nguyen, Quynh-Nhu, Gomez, Daniel R., Liao, Zhongxing, Xu, Ting
Publicado no Chronic Dis Transl Med (2018)

Impact of one-week preoperative physical training on clinical outcomes of surgical lung cancer patients with limited lung function: a randomized trial

Por Lai, Yutian, Wang, Xin, Zhou, Kun, Su, Jianhuan, Che, Guowei
Publicado no Ann Transl Med (2019)

Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer

Por Mohan, Sumitra, Chemi, Francesca, Brady, Ged
Publicado no Transl Lung Cancer Res (2017)

Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer

Por Huynh, Caroline, Walsh, Logan A., Spicer, Jonathan D.
Publicado no Transl Lung Cancer Res (2021)

B cells in lung cancer—not just a bystander cell: a literature review

Por Leong, Tracy L., Bryant, Vanessa L.
Publicado no Transl Lung Cancer Res (2021)

Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer

Por Hamada, Akira, Soh, Junichi, Mitsudomi, Tetsuya
Publicado no Transl Lung Cancer Res (2021)

The KEY for chemo-immunotherapy combination: taking NOTEs from squamous cell lung cancer

Por Reale, Maria Lucia, De Luca, Emmanuele, Di Maio, Massimo
Publicado no Transl Lung Cancer Res (2020)

Antiproliferative effect of Toona sinensis leaf extract on non–small-cell lung cancer

Por Yang, Chih-Jen, Huang, Yu-Jung, Wang, Cheng-Yuan, Wang, Pei-Hui, Hsu, Hseng-Kuang, Tsai, May-Jywan, Chen, Yu-Chu, Bharath Kumar, V., Huang, Ming-Shyan, Weng, Ching-Feng
Publicado no Transl Res (2010)

Nivolumab in pre-treated advanced non-small cell lung cancer: long term follow up data from the Dutch expanded access program and routine clinical care

Por Schouten, Robert D., Egberink, Lucie, Muller, Mirte, De Gooijer, Cornedine J., van Werkhoven, Erik, van den Heuvel, Michel M., Baas, Paul
Publicado no Transl Lung Cancer Res (2020)

PACIFIC: shifting tides in the treatment of locally advanced non-small cell lung cancer

Por Bang, Andrew, Schoenfeld, Jonathan D., Sun, Alexander Y.
Publicado no Transl Lung Cancer Res (2019)

Angiogenesis and lung cancer: ramucirumab prolongs survival in 2(nd)-line metastatic NSCLC

Por Das, Millie, Wakelee, Heather
Publicado no Transl Lung Cancer Res (2014)